| Outcome Measures: |
Primary: eGFR Change, Change in Cys-C eGFR over time, The difference in Cystatin C eGFR between baseline and 6 months will be measured|eGFR Change, Change in Creatinine eGFR over time, The difference in Creatinine eGFR between baseline and 6 months will be measured | Secondary: Serum Uric Acid Change, Change in Serum Uric Acid, The difference in Serum Uric Acid between baseline and 6 months will be measured|Systolic Blood Pressure, Change in systolic blood pressure, The difference in clinic systolic blood pressure between baseline and 6 months will be measured|Diastolic Blood Pressure, Change in diastolic blood pressure, The difference in clinic diastolic blood pressure between baseline and 6 months will be measured | Other: Serum High Sensitivity C-reactive Protein (Hs-CRP), Compare the mean difference of serum hs-CRP from baseline to 6 months between groups, Serum hs-CRP will be measured at baseline and 6 months|Interleukin 18, Change in interleukin 18, Serum interleukin 18 will be measured at baseline, 3 months, and 6 months|Serum Nlrp3, Change in serum Nlrp3, Serum Nlrp3 will be measured at baseline, 3 months, and 6 months|Urine Neutrophil Gelatinase-associated Lipocalin (NGAL), Change in urine NGAL, Urine NGAL will be measured at baseline, 3 months, and 6 months|Urine Endothelin-1 (ET-1), Change in urine ET-1, Urine ET-1 will be measured at baseline, 3 months, and 6 months|Urine Kidney Injury Molecule-1 (KIM-1), Change in urine KIM-1, Urine KIM-1 will be measured at baseline, 3 months, and 6 months|Urine N-acetyl-Beta-D-Glucosaminidase (NAG), Change in urine NAG, Urine NAG will be measured at baseline, 3 months, and 6 months
|
